The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Environmental factors and risk for hepatocellular carcinoma
Open accessAbstract
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most important risk factors for the development of hepatocellular carcinoma (HCC) in humans. HBV is the primary cause of HCC in high-risk areas including China and Africa, whereas in developed countries such as the United States, HCV plays a more prominent role and is at least partially responsible for the increase in HCC incidence in this country. Humans are exposed to hepatocarcinogenic aflatoxins through ingestion of moldy foods, a consequence of poor storage of susceptible grains. Highly exposed populations are primarily in sub-Sahara Africa and Asia, where dietary aflatoxins significantly enhance the carcinogenic effects of viral hepatitis. Heavy, long-term alcohol use is a risk factor for HCC, whereas moderate use (1-3 drinks/day) is not. Constituents of cigarette smoke are hepatic carcinogens in animals, and there is mounting evidence that the liver is an organ susceptible to tobacco carcinogenicity. Diabetic patients are at risk for HCC probably as a result of the hepatic injury, fibrosis, and eventual cirrhosis resulting from fatty liver disease. Given the current epidemic of obesity and diabetes in the United States, this risk factor will be increasingly important. Increased risk for HCC is evident in young noncirrhotic users of oral contraceptives in the United States and Europe. In summary, risk factors for HCC are identifiable in most patients and primarily are associated with chronic hepatic injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Chen, C.-J., Chen, C., Wu, M.-M., & Kuo, T.-L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.380 · Cited by 773
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Self-citationDonato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342402 · Cited by 668
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
Self-citationWideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Changing incidence of hepatocellular carcinoma in Japan.
Okuda, K., Fujimoto, I., Hanai, A., & Urano, Y. (1987) · PubMed · Cited by 328
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
Yeh, F.-S., Yu, M. C., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1990) · Health Policy · doi:10.1016/0168-8510(90)90389-u · Cited by 324
Self-citationMuto, Y., Moriwaki, H., & Shiratori, Y. (1998) · Digestion · doi:10.1159/000051435 · Cited by 315
Ingested Arsenic and Internal Cancer: A Historical Cohort Study Followed for 33 Years
Tsuda, T., Babazono, A., Yamamoto, E., Kurumatani, N., Mino, Y., Ogawa, T., Kishi, Y., & Aoyama, H. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117421 · Cited by 314
Aflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan, G. N. (1992) · PubMed · Cited by 280
Yuan, J., Govindarajan, S., Arakawa, K., & Yu, M. C. (2004) · Cancer · doi:10.1002/cncr.20427 · Cited by 275
Self-citationMcGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe-Bonnie, A., & Ofori-Adjei, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2384 · Cited by 275
Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma
Muto, Y., Moriwaki, H., & Saito, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401315 · Cited by 265
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
Wang, L.-Y., Hatch, M., Chen, C.-J., Levin, B., You, S.-L., Lu, S.-N., Wu, M.-H., Wu, W.-P., Wang, L.-W., Wang, Q., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<620::aid-ijc5>3.0.co;2-w · Cited by 259
Ming, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36366 · Cited by 233
ORONASAL OBSTRUCTION, LUNG VOLUMES, AND ARTERIAL OXYGENATION
Rodenstein, D. O., & Stănescu, D. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91643-1 · Cited by 212
Horizontal transmission of hepatitis B virus.
Gray Davis, L., Weber, D., & Lemon, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92876-6 · Cited by 208
Yu, M. C., Henderson, B. E., Tong, M. J., & Govindarajan, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1820 · Cited by 190
Self-citationCholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
Parkin, D. M., Ohshima, H., Srivatanakul, P., & Vatanasapt, V. (1993) · PubMed · Cited by 187
Epidemiology of Hepatocellular Carcinoma
Yu, M. C., Yuan, J.-M., Govindarajan, S., & Ross, R. K. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/371801 · Cited by 179
Self-citationKew, M. C., Yu, M.-C., Kedda, M., Coppin, A., Sarkin, A., & Hodkinson, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70233-6 · Cited by 169
Self-citationYu, M. C., Skipper, P. L., Taghizadeh, K., Tannenbaum, S. R., Chan, K. K., Henderson, B. E., & Ross, R. K. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.9.712 · Cited by 168
Self-citationOral contraceptives and hepatocellular carcinoma.
Neuberger, J., Forman, D., Doll, R., & Williams, R. (1986) · BMJ · doi:10.1136/bmj.292.6532.1355 · Cited by 168
Yu, M.-W., Horng, I.-S., Hsu, K.-H., Chiang, Y.-C., Liaw, Y. F., & Chen, C.-J. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010016 · Cited by 164
Self-citationWang, L., You, S., Lu, S., Ho, H. C., Wu, M. H., Sun, C. A., Yang, H., & Chen, C. (2003) · Cancer Causes & Control · doi:10.1023/a:1023636619477 · Cited by 157
Trichopoulos, D., Τζώνου, Α., Kaklamani, E., Zavitsanos, X., Koumantaki, Y., Day, N., Muñóz, N., & Trichopoulou, A. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390109 · Cited by 114
Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.
Yu, M., Hsieh, H. H., Pan, W., Yang, C., & Chen, C. (1995) · PubMed · Cited by 111
Self-citationChen, C., Yu, M., Liaw, Y., Wang, L. W., Chiamprasert, S., Matin, F., Hirvonen, A., Bell, D. A., & Santella, R. M. (1996) · PubMed Central · Cited by 109
Self-citationChen, Z., Liu, B., Boreham, J., Wu, Y., Chen, J., & Peto, R. (2003) · International Journal of Cancer · doi:10.1002/ijc.11342 · Cited by 107
TRANSMISSION OF HEPATITIS B ANTIGENS FROM SYMPTOM FREE CARRIER MOTHERS TO THE FETUS AND THE INFANT
WONG, V. C. W., Lee, A. K. Y., & Ip, H. M. H. (1980) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1980.tb04458.x · Cited by 101
A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China
Yuan, J., Ross, R. K., Stanczyk, F. Z., Govindarajan, S., Gao, Y., Henderson, B. E., & Yu, M. C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630405 · Cited by 101
Self-citationSusceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
McGlynn, K. A., Hunter, K. W., LeVoyer, T. E., Roush, J., Wise, P., Michielli, R. A., Shen, F.-M., Evans, A. A., London, W. T., & Buetow, K. H. (2003) · PubMed · Cited by 96
4-Aminobiphenyl DNA Damage in Liver Tissue of Hepatocellular Carcinoma Patients and Controls
Wang, L., Chen, C., Zhang, Y.-J., Tsai, W. Y., Lee, P., Feitelson, M. A., Lee, C.-S., & Santella, R. M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009452 · Cited by 93
Chiba, T., Matsuzaki, Y., Abei, M., Shoda, J., Tanaka, N., Osuga, T., & Aikawa, T. (1996) · PubMed · Cited by 90
Yu, M., Chiu, Y.-H., Chiang, Y.-C., Chen, C., Lee, T., Santella, R. M., Chern, H. D., Liaw, Y., & Chen, C. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009862 · Cited by 82
Self-citationORAL CONTRACEPTIVE USE AND LIVER CANCER
Palmer, J. R., Rosenberg, L. A., Kaufman, D. W., Warshauer, M. E., Stolley, P. D., & Shapiro, S. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115420 · Cited by 79
Female hormone utilisation and risk of hepatocellular carcinoma
Tavani, A., Negri, E., Parazzini, F., Franceschi, S., & Vecchia, C. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.116 · Cited by 76
Combined oral contraceptives and liver cancer
Molina, R., Martinez, L., Salas, O., Dabancens, A., Yun, T., Chen, Z., Hu, Y., Cuadros, A. J., Aristizabal, N., Modan, B., et al. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430215 · Cited by 74
Oral contraceptives and liver cancer
Heinemann, L. A. J., DoMinh, T., Guggenmoos-Holzmann, I., Thie, C., Garbe, E., Feinstein, A. R., Thomas, D. B., Bréchot, C., Spitzer, W. O., Watanabe, V., et al. (1997) · Contraception · doi:10.1016/s0010-7824(97)00158-3 · Cited by 74
Heinemann, L. A. J., DoMinh, T., Guggenmoos-Holzmann, I., Thie, C., Garbe, E., Feinstein, A. R., Thomas, D. B., Bréchot, C., Spitzer, W. O., Watanabe, V., et al. (1997) · PubMed · Cited by 58
Kew, M. C., Song, E., Mohammed, A., & Hodkinson, J. (1990) · Hepatology · doi:10.1002/hep.1840110221 · Cited by 46
Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis
Clemente, C., Elba, S., Buongiorno, G., Berloco, P. B., Guerra, V., & Leo, A. D. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00843-6 · Cited by 45
Moreno, F. S., Ts, W., Naves, M. M. V., Silveira, E. R., Oloris, S. C. S., da Costa, M. A. L., Dagli, M. L., & Ong, T. P. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc441_11 · Cited by 41
Cigarette smoking and liver cancer among US veterans
Hsing, A. W., McLaughlin, J. K., Hrubec, Z., Blot, W. J., & Fraumeni, J. F. (1990) · Cancer Causes & Control · doi:10.1007/bf00117473 · Cited by 31
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Metadata
- Authors
- Yu, M. C., & Yuan, J.-M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 127
- Issue
- 5
- Pages
- S72-S78
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2037700816
- Cited by
- 426
- References
- 53
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.